Results 21 to 30 of about 25,138 (263)

Therapeutic roles of thiazides and loop diuretics in blood pressure control and renal protection against chronic kidney disease [PDF]

Clinical Hypertension, 2023
Fluid overload secondary to loss of functional nephron mass can elevate blood pressure, which is characteristic of hypertension shown in chronic kidney disease (CKD).
Wonji Jo, Eun Sil Koh, Sungjin Chung
doaj   +2 more sources

Diuretics in chronic kidney disease

Архивъ внутренней медицины, 2020
The issues of diuretic therapy in patients with chronic kidney disease, pharmacokinetics of diuretics, the problem of diuretic resistance, the tactics of using thiazides and loop diuretics in patients with various stages of chronic kidney disease ...
A. I. Dyadyk, G. G. Taradin, Yu. V. Suliman, S. R. Zborovskyy, V. I. Merkuriev   +4 more
doaj   +3 more sources

Continuous infusion versus bolus injection of loop diuretics for congestive heart failure [PDF]

Cochrane Database Syst Rev, 2021
Objectives: This is a protocol for a Cochrane Review (intervention). The objectives are as follows:. To assess the effects of intravenous continuous infusion versus bolus injection of loop diuretics for the initial treatment of acute decompensated heart ...
Zhang J, Zhou C, Ihsan M, Tsangarides A, Ahmed S, Fernando R, Lwin T, Surtee S, Farnell E, Chaudhary M, Lip G, Hill R, Sankaranarayanan R.   +12 more
europepmc   +2 more sources

The potential toxicity of loop diuretics in patients with cardiovascular complications

Journal of Education, Health and Sport, 2018
A patient with cardiovascular complications is a proper candidate for a diuretic treatment. Here, loop diuretics are the drugs with the greatest strength and time of acting, especially when used in urgent cases like exacerbation of heart failure is ...
Grzegorz Liczner, Michał Wiciński, Bartosz Malinowski, Mateusz Ozorowski, Karolina Długi, Sebastian Rewerski   +5 more
doaj   +5 more sources

Loop diuretics for chronic heart failure: a foe in disguise of a friend?

European Heart Journal - Cardiovascular Pharmacotherapy, 2018
Loop diuretics are recommended for relieving symptoms and signs of congestion in patients with chronic heart failure and are administered to more than 80% of them. However, several of their effects have not systematically been studied.
Chris J Kapelios, Konstantinos Malliaras, Elisabeth Kaldara   +2 more
exaly   +1 more source

Association between changes in loop diuretic dose and outcomes in acute heart failure

ESC Heart Failure, 2023
Aims Little is known about the association between the starting of or dose changes in loop diuretics during acute heart failure (AHF) hospitalization and post‐discharge outcomes. We investigated the clinical impact of starting loop diuretics and changing
Yuta Seko, Takao Kato, Takeshi Morimoto, Hidenori Yaku, Yasutaka Inuzuka, Yodo Tamaki, Neiko Ozasa, Masayuki Shiba, Erika Yamamoto, Yusuke Yoshikawa, Yugo Yamashita, Takeshi Kitai, Ryoji Taniguchi, Moritake Iguchi, Kazuya Nagao, Takafumi Kawai, Akihiro Komasa, Ryusuke Nishikawa, Yuichi Kawase, Takashi Morinaga, Mamoru Toyofuku, Yutaka Furukawa, Kenji Ando, Kazushige Kadota, Yukihito Sato, Koichiro Kuwahara, Takeshi Kimura, for the KCHF Study Investigators   +27 more
doaj   +1 more source

Association between intestinal oedema and oral loop diuretic resistance in hospitalized patients with acute heart failure

ESC Heart Failure, 2021
Aims Intestinal oedema is one of the manifestations associated with right‐sided heart failure (HF), which is known to be associated with poorer patient outcomes.
Yuki Ikeda, Shunsuke Ishii, Kenji Maemura, Takumi Oki, Mayu Yazaki, Teppei Fujita, Takeru Nabeta, Emi Maekawa, Toshimi Koitabashi, Junya Ako   +9 more
doaj   +1 more source

Diuretic treatment before and after transcatheter aortic valve implantation: A Danish nationwide study.

PLoS ONE, 2023
ObjectivesWe examined loop diuretic treatment before and 1-year after transcatheter aortic valve implantation (TAVI), as a proxy for changes in symptom severity and secondly assessed how changes in loop diuretics related to mortality risk ...
Xenia Begun, Jawad Haider Butt, Søren Lund Kristensen, Peter Ejvin Weeke, Ole De Backer, Morten Schou, Lars Køber, Emil Loldrup Fosbøl   +7 more
doaj   +1 more source

Adherence to Pharmacotherapies After Heart Transplantation in Relation to Multimorbidity and Socioeconomic Position: A Nationwide Register-Based Study

Transplant International, 2023
No studies have examined the impact of multimorbidity and socioeconomic position (SEP) on adherence to the pharmacological therapies following heart transplantation (HTx).
Rikke E. Mols, Rikke E. Mols, István Bakos, Brian B Løgstrup, Brian B Løgstrup, Erzsébet Horváth-Puhó, Finn Gustafsson, Finn Gustafsson, Hans Eiskjær, Hans Eiskjær   +9 more
doaj   +1 more source

European Consensus on use of diuretics in chronic heart failure 2019

Медицинский совет, 2020
The article presents the consensus materials of the European Society of Cardiology on the use of diuretics in chronic heart failure (CHF). Diuretics represent an important class of drugs for the treatment of heart failure from the perspective of evidence
M. V. Leonova
doaj   +1 more source